<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03846076</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00775</org_study_id>
    <nct_id>NCT03846076</nct_id>
  </id_info>
  <brief_title>Internet Delivered CBT for Olfactory Reference Syndrome</brief_title>
  <official_title>Investigating Treatment and Information Processing in Olfactory Reference Syndrome: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Volen Ivanov</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stockholm City Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to test the feasibility and efficacy of, a manual based,
      Internet-delivered, cognitive behaviour therapy (CBT) for Olfactory Reference Syndrome (ORS).
      The secondary aim is to investigate smell sensitivity and body odor in ORS-patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale Modified for olfactory reference syndrome (ORS-YBOCS)</measure>
    <time_frame>Change from baseline (week 0) to post-treatment (week 10).</time_frame>
    <description>The instrument is a 12-item clinician-administered scale rating the severity of ORS symptoms during the past week. Each item is scored along a Likert scale ranging from 0 (least extreme) to 4 (most extreme), with higher total scores indicating more severe ORS symptoms (range 0-48).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Yale-Brown Obsessive Compulsive Scale Modified for olfactory reference syndrome - Self Report (ORS-YBOCS-SR)</measure>
    <time_frame>Change from baseline (week 0) to post-treatment (week 10).</time_frame>
    <description>The instrument is a12-item self-administered scale rating the severity of ORS symptoms during the past week.
Each item is scored along a Likert scale ranging from 0 (least extreme) to 4 (most extreme), with higher total scores indicating more severe ORS symptoms (range 0-48).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)</measure>
    <time_frame>Change from baseline (week 0) to post-treatment (week 10).</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Olfactory Reference Syndrome</condition>
  <arm_group>
    <arm_group_label>Internet-delivered CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 weeks of CBT delivered via the Internet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive behavioral therapy</intervention_name>
    <description>Cognitive behavioral therapy</description>
    <arm_group_label>Internet-delivered CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary diagnosis of ORS

          -  Outpatients

          -  Male or female

          -  Signed informed consent

          -  Have regular access to a computer with Internet access and skills to use the web

        Exclusion Criteria:

          -  Not able to read or understand the basics of the ICBT self-help material

          -  Psychotropic medication changes within two months prior to treatment

          -  Completed CBT for ORS within last 12 months

          -  Ongoing substance dependence or misuse

          -  Lifetime bipolar disorder or psychosis

          -  Suicidal ideation

          -  Axis II diagnosis that could jeopardize treatment participation

          -  Serious physical illness that will be an obstacle in ICBT

          -  Other ongoing psychological treatments that could affect ORS symptoms

          -  Epilepsia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Volen Ivanov, PhD</last_name>
    <phone>+46 8585 85 722</phone>
    <email>volen.ivanov@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst Stockholm, Huddinge, Sweden, 141 86</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volen Ivanov, PhD</last_name>
      <email>volen.ivanov@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 16, 2019</study_first_submitted>
  <study_first_submitted_qc>February 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2019</study_first_posted>
  <last_update_submitted>February 20, 2019</last_update_submitted>
  <last_update_submitted_qc>February 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Volen Ivanov</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

